Effects of estrogen-only therapy on LDL oxidation in women with hysterectomy: does paraoxonase genotype play a role?
- PMID: 16023312
- DOI: 10.1016/j.maturitas.2005.05.017
Effects of estrogen-only therapy on LDL oxidation in women with hysterectomy: does paraoxonase genotype play a role?
Abstract
Objectives: This study investigated the effects of estrogen-only therapy on lipid profile (through susceptibility of low density lipoproteins to oxidation) and on oxidant-antioxidant parameters in surgical menopausal women. PON genotypes are also evaluated considering that they may be associated with the personal differences observed in antioxidant effects induced by estrogen.
Methods: Thirty women who had undergone hysterectomy+bilateral ovariectomy in the last 3 years, with causes other than malignancy were included and given estrogen-only (Premarin-Wyeth Inc. 0.625 mg/day/6 months, equine conjugated estrogen). Blood samples were collected at baseline, first and sixth month of treatment. Serum (total antioxidant activity-TAO and PON activity), erythrocyte (TBARS and catalase activity), LDL and Cu2+ induced ox-LDL (TBARS and diene levels) samples were evaluated and PON1 192 polymorphisms were determined by PCR amplification & restriction enzyme digestion.
Results: At the sixth month, a higher TAO activity (p=0.016) and a lower eTBARS (p=0.028) were detected compared to the basal values. LDL and Cu induced ox-LDL TBARS levels at the sixth month of treatment were significantly (p=0.012 and 0.026, respectively) lower compared to the pretreatment values. Baseline eTBARS (p=0.007), LDL TBARS (p=0.044) and eCAT (p=0.033) activities were significantly higher in homozygote Q allele carriers compared to subjects with R allele. LDL TBARS and Cu2+ induced ox-LDLTBARS of QQ subjects (p=0.018 and 0.050) as well as LDL TBARS of QR subjects (p=0.044) showed a significant decrease with estrogen-only treatment.
Conclusions: Our study drives the attention to PON polymorphism in postmenopausal women who have risk for atherosclerosis. Although our data is limited, this study is the first that focuses on the role of PON genotypes in antiatherosclerotic effects of estrogen-only and provides important points for further studies.
Similar articles
-
Effect of lower dose of oral conjugated equine estrogen on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women.Circulation. 2003 Aug 19;108(7):808-13. doi: 10.1161/01.CIR.0000084552.54277.64. Epub 2003 Aug 4. Circulation. 2003. PMID: 12900341 Clinical Trial.
-
Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients.Curr Med Res Opin. 2005 May;21(5):777-84. doi: 10.1185/030079905X45170. Curr Med Res Opin. 2005. PMID: 15969877 Clinical Trial.
-
HDL capacity to inhibit LDL oxidation in well-trained triathletes.Life Sci. 2006 May 22;78(26):3074-81. doi: 10.1016/j.lfs.2005.12.015. Epub 2006 Feb 20. Life Sci. 2006. PMID: 16488445
-
[Paraoxonase--important enzyme of the lipid metabolism and potential ally in the antiatherosclerotic treatment].Pol Merkur Lekarski. 2010 Nov;29(173):325-7. Pol Merkur Lekarski. 2010. PMID: 21268919 Review. Polish.
-
Review: The role of paraoxonase in cardiovascular diseases.Ann Clin Lab Sci. 2015 Spring;45(2):226-33. Ann Clin Lab Sci. 2015. PMID: 25887882 Review.
Cited by
-
The Role of PON1 Variants in Disease Susceptibility in a Turkish Population.Glob Med Genet. 2020 Aug;7(2):41-46. doi: 10.1055/s-0040-1715568. Epub 2020 Aug 31. Glob Med Genet. 2020. PMID: 32939514 Free PMC article. Review.
-
Estradiol enhances cell-associated paraoxonase 1 (PON1) activity in vitro without altering PON1 expression.Biochem Biophys Res Commun. 2010 Jul 2;397(3):441-6. doi: 10.1016/j.bbrc.2010.05.120. Epub 2010 May 27. Biochem Biophys Res Commun. 2010. PMID: 20510879 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous